Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-06

Clinical Trial Update: Mirai-MRI: Validation of AI Models for Breast Cancer Risk [NA]

View source ↗

Summary

Ongoing recruitment for Mirai-MRI, a study validating AI-based MRI models to assess breast cancer risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: Cancer Risk, Breast Cancer Risk | NA | Status: RECRUITING